checkAd
    Startseite > Aktien > Advicenne > Nachrichten
    Advicenne Aktie
    1,8070
     
    EUR
    +5,80 %
    +0,0990 EUR
    Letzter Kurs 09.05.24 Lang & Schwarz
    1,7160
     
    EUR
    594 STK
    Geldkurs 09.05.24
    1,8980
     
    EUR
    594 STK
    Briefkurs 09.05.24
    ISIN: FR0013296746 · WKN: A2H8SU · Frankreich

    Neueste Nachrichten

    Advicenne: Strong improvement of 2023 results thanks to sustained commercial activity on Sibnayal
    28.03.24 · Business Wire (engl.) · Advicenne
    FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.
    25.03.24 · Business Wire (engl.) · Advicenne
    Advicenne Reports 2023 Gross Sales1 up 20% to €4.43 Million
    23.01.24 · Business Wire (engl.) · Advicenne
    Advicenne Announces Its 2024 Financial Calendar
    28.12.23 · Business Wire (engl.) · Advicenne
    Advicenne announces the results of its capital increase with preferential subscription rights
    02.10.23 · Business Wire (engl.) · Advicenne
    Advicenne Announces Its Participation in Several Scientific Conferences and the Presentation of Updated Clinical Results About ADV7103
    25.09.23 · Business Wire (engl.) · Advicenne
    Advicenne Launches a Capital Increase With Preferential Subscription Rights (“PSR”) to Accelerate Growth in Europe and Optimize Clinical Development of ADV7103
    11.09.23 · Business Wire (engl.) · Advicenne
    Advicenne Reports its First Half Financial Results as of June 30, 2023 and Updates on Its Activities
    11.09.23 · Business Wire (engl.) · Advicenne
    Advicenne Announces 51% Growth in Sibnayal Gross Sales in H1 2023 to almost €1.0 Million
    12.07.23 · Business Wire (engl.) · Advicenne
    Advicenne Announces Long-Term Results of the European Clinical Development Program for ADV7103
    14.06.23 · Business Wire (engl.) · Advicenne
    Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting
    09.06.23 · Business Wire (engl.) · Advicenne
    Advicenne annual combined general meeting of June 8, 2023
    19.05.23 · Business Wire (engl.) · Advicenne